The study also proposes disrupting the heterocomplex as a potential therapeutic target to inhibit cancer invasion and metastasis, emphasizing the important roles of CXCL12 and CXCR4 in this process (Pirani et al., 2024). Here, CXCR4 is linked to cancer.